Shanghai Haohai Biological Technology Co Ltd
F:5HB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Shanghai Haohai Biological Technology Co Ltd (5HB) under the Base Case is 2.56 EUR per share.
Compared with the current market price of 1.79 EUR, the stock appears
Undervalued by 30% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Shanghai Haohai Biological Technology Does
Shanghai Haohai Biological Technology makes medical biomaterials and related products used in hospitals and clinics. Its core business is eye care, where it sells products used in eye surgery and other ophthalmic treatments. It also has products for surgical anti-adhesion, wound care, and medical aesthetics, such as injectable materials used by doctors in cosmetic procedures.
- Headquarters
- China CN
- Employees
- 2 110
- IPO date
- Apr 30, 2015
Balance Sheet
Continue 5HB Research
Decided on Shanghai Haohai Biological Technology? Get an email when 5HB reaches the price you’d buy at. Free with an account.
Other Shanghai Haohai Biological Technology listings
What is the Intrinsic Value of one 5HB stock?
The intrinsic value for
Shanghai Haohai Biological Technology Co Ltd (5HB) under the Base Case is 2.56 EUR.
Is 5HB stock undervalued or overvalued?
Compared with the current market price of 1.79 EUR, the stock appears Undervalued by 30% .